This Enforcement Notice provides guidance to advertiser’s using their social media presence to advertise botulinum toxin products – which are prescription-only medicines (POMs) – to the public. Advertisers may neither directly promote a POM to consumers, nor indirectly promote a POM by implying one that may be offered.

Related guidance and information

Botox and other POMs

Anti-ageing: Botulinum toxin products

Guidance on the marketing of surgical and non-surgical cosmetic procedures



More on